|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 822.90 BDT | +4.03% |
|
+8.18% | +16.23% |
| Market Cap | 1.82B 14.73M 12.87M 11.88M 10.95M 20.63M 1.42B 21.09M 142M 55.84M 695M 55.31M 54.1M 2.39B | P/E 2024 |
189x | P/E 2025 | 369x |
|---|---|---|---|---|---|
| Enterprise Value | 2.32B 18.84M 16.46M 15.19M 14M 26.39M 1.81B 26.97M 182M 71.41M 888M 70.74M 69.19M 3.06B | EV / Sales 2024 |
10.4x | EV / Sales 2025 | 10.7x |
| Free-Float |
22.75% | Yield 2024 |
0.13% | Yield 2025 | 0.12% |
| 1 day | +4.03% | ||
| 1 week | +8.18% | ||
| Current month | +8.78% | ||
| 1 month | +7.99% | ||
| 3 months | +8.98% | ||
| 6 months | +15.98% | ||
| Current year | +16.23% |
| 1 week | 757 |  | 833 |
| 1 month | 750 | | 833 |
| Current year | 689 | | 833 |
| 1 year | 681 | | 909 |
| 3 years | 511 | | 1,302.3 |
| 5 years | 375.3 | | 1,302.3 |
| 10 years | 295.5 | | 1,302.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
Nurjehan Hudda
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.03% | +8.18% | -3.68% | +53.27% | 16.02M | |
| -0.90% | -0.15% | +13.46% | +79.34% | 48.15B | |
| -0.23% | -1.65% | +65.14% | +115.81% | 35.59B | |
| -0.76% | -1.44% | -4.30% | +37.38% | 11.9B | |
| -0.88% | -0.62% | +16.38% | +89.65% | 11.85B | |
| +0.19% | +2.87% | +34.92% | +127.54% | 9.31B | |
| -0.75% | -0.91% | +18.26% | +37.23% | 6.91B | |
| -9.93% | +0.35% | -29.90% | +14.89% | 6.13B | |
| +3.37% | -0.10% | +49.31% | -4.38% | 7.02B | |
| -2.25% | -2.08% | +0.40% | +218.27% | 6.55B | |
| Average | -0.81% | +0.92% | +16.00% | +76.90% | 14.34B | |
| Weighted average by Cap. | -0.88% | -0.42% | +25.98% | +86.35% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 219M 1.78M 1.55M 1.43M 1.32M 2.49M 171M 2.55M 17.15M 6.74M 83.91M 6.68M 6.53M 289M | 231M 1.87M 1.63M 1.51M 1.39M 2.62M 180M 2.68M 18.03M 7.09M 88.21M 7.02M 6.87M 304M |
| Net income | 9.68M 78.56K 68.65K 63.35K 58.39K 110K 7.56M 112K 757K 298K 3.71M 295K 289K 12.75M | 5.31M 43.07K 37.64K 34.73K 32.02K 60.34K 4.15M 61.68K 415K 163K 2.03M 162K 158K 6.99M |
| Net Debt | 445M 3.61M 3.15M 2.91M 2.68M 5.05M 347M 5.17M 34.77M 13.68M 170M 13.55M 13.25M 586M | 506M 4.11M 3.59M 3.31M 3.05M 5.75M 396M 5.88M 39.59M 15.57M 194M 15.42M 15.09M 667M |
Employees
474
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/07/26 | BDT 822.90 | +4.03% | 12,480 |
| 15/07/26 | BDT 791.00 | +2.51% | 5,963 |
| 14/07/26 | BDT 771.60 | +0.38% | 1,683 |
| 13/07/26 | BDT 768.70 | +1.48% | 1,750 |
| 12/07/26 | BDT 757.50 | -0.42% | 122 |
- Stock Market
- Stocks
- AMBEEPHA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
